Inventor · disambiguated record
Hector Alila
Also filed as: ALILA HECTOR · ALILA HECTOR W · ALILA HECTOR WASUNNA
17 granted patents·18 pending applications·131 citations·filing 1994–2024
93Inventor score
Files withESPERANCE PHARMACEUTICALS INC10PFIZER4A28 THERAPEUTICS INC3LEUSCHNER CAROLA3CELL PATHWAYS INC2
Top patents by PatentIndex Score
35 records- 0186US5889144AFused somatotropin epitopic peptides that potentiate growth hormone activityPFIZER·Filed 1997·Granted Mar 30, 1999·65 cites·15 claims
- 0286US2025327113A1COMPOSITION FOR DETECTING LHRH OR hCG/LH RECEPTOR EXPRESSING TUMORS, CANCERS AND NEOPLASIASA28 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0385US2025092092A1Antibody/drug conjugates and methods of useA28 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0483US8318899B2Lytic domain fusion constructs and methods of making and using sameLEUSCHNER CAROLA·Filed 2009·Granted Nov 27, 2012·7 cites·43 claims
- 0582US10233214B2Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2016·Granted Mar 19, 2019·3 cites·28 claims
- 0682US9492563B2Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·5 cites·31 claims
- 0782US8546535B2Lytic domain fusion constructs and methods of making and using sameLEUSCHNER CAROLA·Filed 2009·Granted Oct 1, 2013·5 cites·57 claims
- 0880US6699894B1Methods for treatment of inflammatory bowel diseaseOSI PHARM INC·Filed 2002·Granted Mar 2, 2004·13 cites·2 claims
- 0979US6479493B1Methods for treatment of type I diabetesCELL PATHWAYS INC·Filed 2001·Granted Nov 12, 2002·12 cites·40 claims
- 1077US9586996B2Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of useALILA HECTOR·Filed 2011·Granted Mar 7, 2017·3 cites·47 claims
- 1174US2022048951A1Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1273US2021324443A1METHODS FOR DIAGNOSING LHRH OR hCG/LH RECEPTOR EXPRESSING TUMORS, CANCERS AND NEOPLASIASESPERANCE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1370US6906064B2Method for treating a patient with neoplasia using IressaFiled 2002·Granted Jun 14, 2005·2 cites·3 claims
- 1470US6465494B1Methods for treatment of cystic fibrosisCELL PATHWAYS INC·Filed 2001·Granted Oct 15, 2002·5 cites·37 claims
- 1569US11066693B2Methods for diagnosing LHRH or hCG/LH receptor expressing tumors, cancers and neoplasiasESPERANCE PHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·0 cites·18 claims
- 1668US2025009900A1Oxazaphosphorine antibody drug conjugates and methods of useLA LIFE PRODUCTS LLC·Filed 2024·Application pending·0 cites
- 1764US10729740B2Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2017·Granted Aug 4, 2020·0 cites·20 claims
- 1863US2020353032A1Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1962US2019367558A1Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2059US9255134B2Lytic domain fusion constructs and methods of making and using sameESPERANCE PHARMACEUTICALS INC·Filed 2013·Granted Feb 9, 2016·0 cites·35 claims
- 2159US2006252762A1Methods for treatment of multiple sclerosisWHITEHEAD CLARK M·Filed 2006·Application pending·0 cites
- 2257US2006100210A1Methods for treatment of sclerodermaWHITEHEAD CLARK M·Filed 2005·Application pending·0 cites
- 2357US2003220252A1Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analogFiled 2003·Application pending·0 cites
- 2455US2002193286A1Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analogFiled 2002·Application pending·0 cites
- 2554US10093961B2Methods for diagnosis of and predicting treatment efficacy of hormone receptor expressing tumors, cancers and neoplasiasLEUSCHNER CAROLA·Filed 2010·Granted Oct 9, 2018·0 cites·5 claims
- 2653US2024228542A1Lytic domain fusion constructs, checkpoint inhibitors, and methods of making and using sameA28 THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2751US2003073741A1Methods for treatment of multiple sclerosisFiled 2002·Application pending·0 cites
- 2849US5686268AFused proteinsPFIZER·Filed 1995·Granted Nov 11, 1997·9 cites·13 claims
- 2949US2003073711A1Methods for treatment of sclerodermaFiled 2001·Application pending·0 cites
- 3046US2003176316A1Methods for treatment of rheumatoid arthritisFiled 2002·Application pending·0 cites
- 3143US2003073740A1Methods for treatment of lupus erythematosusFiled 2001·Application pending·0 cites
- 3243US2014161767A1Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using sameUNIV LOUISIANA STATE·Filed 2013·Application pending·0 cites
- 3335US2011124564A1Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using sameESPERANCE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3431US5604214AReduction of boar odor in meatPFIZER·Filed 1994·Granted Feb 18, 1997·2 cites·17 claims
- 3530US6328974B1Immunogenic compositions that potentiate growth hormone activityPFIZER·Filed 1999·Granted Dec 11, 2001·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Hector Alila files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →